secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001682852-24-000031
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna shareholders approve special meeting right and officer exculpation amendments
--------------------------------------------------------------------------------

- Shareholders approved right for holders of at least 20% of shares to call a special meeting.
- Shareholders approved officer exculpation amendment under new Delaware law provisions.
- All three Class III directors (Langer, Nabel, Tallett) elected with strong support.
- Say-on-pay and ratification of EY as auditor each passed with overwhelming majorities.
- Amendments and restated certificate became effective upon filing with Delaware Secretary of State on May 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285224000031/0001682852-24-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285224000031/mrna-20240506.htm
  HTML page:      https://secwatch.observer/filing/0001682852-24-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer